"Daptomycin" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A cyclic lipopeptide antibiotic that inhibits GRAM-POSITIVE BACTERIA.
| Descriptor ID |
D017576
|
| MeSH Number(s) |
D04.345.566.270 D10.477.500 D12.644.365.500 D12.644.641.270
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Daptomycin".
Below are MeSH descriptors whose meaning is more specific than "Daptomycin".
This graph shows the total number of publications written about "Daptomycin" by people in this website by year, and whether "Daptomycin" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2006 | 1 | 0 | 1 |
| 2013 | 1 | 0 | 1 |
| 2016 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Daptomycin" by people in Profiles.
-
Daptomycin for Complicated Skin Infections: A Randomized Trial. Pediatrics. 2017 Mar; 139(3).
-
Influence of Minimum Inhibitory Concentration in Clinical Outcomes of Enterococcus faecium Bacteremia Treated With Daptomycin: Is it Time to Change the Breakpoint? Clin Infect Dis. 2016 06 15; 62(12):1514-1520.
-
Staphylococcus aureus metabolic adaptations during the transition from a daptomycin susceptibility phenotype to a daptomycin nonsusceptibility phenotype. Antimicrob Agents Chemother. 2015 Jul; 59(7):4226-38.
-
Activity of daptomycin with or without 25 percent ethanol compared to combinations of minocycline, EDTA, and 25 percent ethanol against methicillin-resistant Staphylococcus aureus isolates embedded in biofilm. Antimicrob Agents Chemother. 2013 Apr; 57(4):1998-2000.
-
Comparative genome sequencing of an isogenic pair of USA800 clinical methicillin-resistant Staphylococcus aureus isolates obtained before and after daptomycin treatment failure. Antimicrob Agents Chemother. 2011 May; 55(5):2018-25.
-
Daptomycin-oxacillin combinations in treatment of experimental endocarditis caused by daptomycin-nonsusceptible strains of methicillin-resistant Staphylococcus aureus with evolving oxacillin susceptibility (the "seesaw effect"). Antimicrob Agents Chemother. 2010 Aug; 54(8):3161-9.
-
Daptomycin for the treatment of vancomycin resistant Enterococcus faecium bacteremia. Scand J Infect Dis. 2006; 38(4):290-2.
-
Treatment evaluation of experimental staphylococcal infections: comparison of beta-lactam, lipopeptide, and glycopeptide antimicrobial therapy. J Lab Clin Med. 1990 Nov; 116(5):697-706.